product summary
Loading...
company name :
MyBioSource
product type :
protein
product name :
Recombinant Bordetella pertussis Pertussis toxin subunit 1
catalog :
MBS1095030
quantity :
0.05 mg (E-Coli)
price :
185 USD
more info or order :
product information
catalog number :
MBS1095030
products type :
Recombinant Protein
products full name :
Recombinant Bordetella pertussis Pertussis toxin subunit 1
products short name :
Pertussis toxin subunit 1
products name syn :
Islet-activating protein S1; IAP S1; NAD-dependent ADP-ribosyltransferase (EC:2.4.2.-)
other names :
pertussis toxin subunit 1; Pertussis toxin subunit 1; pertussis toxin subunit 1; Islet-activating protein S1; IAP S1; NAD-dependent ADP-ribosyltransferase (EC:2.4.2.-)
products gene name :
ptxA
other gene names :
ptxA; ptxA; PTX S1; IAP S1
uniprot entry name :
TOX1_BORPE
host :
E Coli or Yeast or Baculovirus or Mammalian Cell
sequence positions :
35-269
sequence length :
269
sequence :
DDPPATVYRYDSRPPEDVFQNGFTAWGNNDNVLDHLTGR
SCQVGSSNSAFVSTSSSRRYTEVYLEHRMQEAVEAERAG
RGTGHFIGYIYEVRADNNFYGAASSYFEYVDTYGDNAGR
ILAGALATYQSEYLAHRRIPPENIRRVTRVYHNGITGET
TTTEYSNARYVSQQTRANPNPYTSRRSVASIVGTLVRMA
PVIGACMARQAESSEAMAAWSERAGEAMVLVYYESIAYS
F
purity :
Greater than 90% as determined by SDS-PAGE.
form :
Liquid containing glycerol; lyophilization may be available upon request.
storage stability :
Store at -20 degree C, for extended storage, conserve at -20 degree C or -80 degree C.
products description :
S1 is an NAD-dependent ADP-ribosyltransferase, which plays a crucial role in the pathogenesis of B. pertussis causing disruption of normal host cellular regulation. It catalyzes the ADP-ribosylation of a cysteine in the alpha subunit of host heterotrimeric G proteins. In the absence of G proteins it also catalyzes the cleavage of NAD+ into ADP-ribose and nicotinamide. It irreversibly uncouples the G-alpha GTP-binding proteins from their membrane receptors.
products references :
Cloning and sequencing of the pertussis toxin genes operon structure and gene duplication.Nicosia A., Perugini M., Franzini C., Casagli M.C., Borri M.G., Antoni G., Almoni M., Neri P., Ratti G., Rappuoli R.Proc. Natl. Acad. Sci. U.S.A. 83:4631-4635(1986) Pertussis toxin gene nucleotide sequence and genetic organization.Locht C., Keith J.M.Science 232:1258-1264(1986) A unique sequence of the Bordetella pertussis toxin operon.Loosmore S.M., Cunningham J.D., Bradley W.R., Yao E.L., Dekaban G.A., Klein M.H.Nucleic Acids Res. 17:8365-8365(1989) Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands temporal trends and evidence for vaccine-driven evolution.Mooi F.R., van Oirschot H., Heuvelman K., van der Heide H.G., Gaastra W., Willems R.J.Infect. Immun. 66:670-675(1998) Intranasal murine model of Bordetella pertussis infection II. Sequence variation and protection induced by a tricomponent acellular vaccine.Boursaux-Eude C., Thiberge S., Carletti G., Guiso N.Vaccine 17:2651-2660(1999) Temporal trends in circulating Bordetella pertussis strains in Australia.Poynten M., McIntyre P.B., Mooi F.R., Heuvelman G.L., Gilbert G.L.Epidemiol. Infect. 132:185-193(2004) Wang Y., Zhang S., Lei D. Bordetella pertussis toxin gene encoding subunit S1.Mallya A.D., Kumar M., Reddy M.N., Seshubabu B., Deobagkar D.D., Kapre S.V. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.Parkhill J., Sebaihia M., Preston A., Murphy L.D., Thomson N.R., Harris D.E., Holden M.T.G., Churcher C.M., Bentley S.D., Mungall K.L., Cerdeno-Tarraga A.-M., Temple L., James K.D., Harris B., Quail M.A., Achtman M., Atkin R., Baker S., Basham D., Bason N., Cherevach I., Chillingworth T., Collins M., Cronin A., Davis P., Doggett J., Feltwell T., Goble A., Hamlin N., Hauser H., Holroyd S., Jagels K., Leather S., Moule S., Norberczak H., O'Neil S., Ormond D., Price C., Rabbinowitsch E., Rutter S., Sanders M., Saunders D., Seeger K., Sharp S., Simmonds M., Skelton J., Squares R., Squares S., Stevens K., Unwin L., Whitehead S., Barrell B.G., Maskell D.J.Nat. Genet. 35:32-40(2003) Identification of a region in the S1 subunit of pertussis toxin that is required for enzymatic activity and that contributes to the formation of a neutralizing antigenic determinant.Cieplak W., Burnette W.N., Mar V.L., Kaljot K.T., Morris C.F., Chen K.K., Sato H., Keith J.M.Proc. Natl. Acad. Sci. U.S.A. 85:4667-4671(1988) Identification of an active-site residue in subunit S1 of pertussis toxin by photocrosslinking to NAD.Cockle S.A.FEBS Lett. 249:329-332(1989) Role of tryptophan 26 in the NAD glycohydrolase reaction of the S-1 subunit of pertussis toxin.Cortina G., Barbieri J.T.J. Biol. Chem. 264:17322-17328(1989) Further analysis of the sequence of the S1 subunit of pertussis toxin.Pizza M., Bugnoli M., Puccini P., Siciliano R., Marino G., Rappuoli R.Infect. Immun. 59:1177-1179(1991) A proposed mechanism of ADP-ribosylation catalyzed by the pertussis toxin S1 subunit.Locht C., Antoine R.Biochimie 77:333-340(1995) Synergistic binding of RNA polymerase and BvgA phosphate to the pertussis toxin promoter of Bordetella pertussis.Boucher P.E., Stibitz S.J. Bacteriol. 177:6486-6491(1995) Mutations in the S1 subunit of pertussis toxin that affect secretion.Craig-Mylius K.A., Stenson T.H., Weiss A.A.Infect. Immun. 68:1276-1281(2000) Membrane localization of the S1 subunit of pertussis toxin in Bordetella pertussis and implications for pertussis toxin secretion.Farizo K.M., Fiddner S., Cheung A.M., Burns D.L.Infect. Immun. 70:1193-1201(2002) DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis.Stenson T.H., Weiss A.A.Infect. Immun. 70:2297-2303(2002) Temporal expression of pertussis toxin and Ptl secretion proteins by Bordetella pertussis.Rambow-Larsen A.A., Weiss A.A.J. Bacteriol. 186:43-50(2004) The crystal structure of pertussis toxin.Stein P.E., Boodhoo A., Armstrong G.D., Cockle S.A., Klein M.H., Read R.J.Structure 2:45-57(1994) Crystal structure of the pertussis toxin-ATP complex a molecular sensor.Hazes B., Boodhoo A., Cockle S.A., Read R.J.J. Mol. Biol. 258:661-671(1996)
ncbi gi num :
33594638
ncbi acc num :
NP_882282.1
ncbi gb acc num :
NC_002929.2
uniprot acc num :
P04977
ncbi mol weight :
30.3kD
ncbi pathways :
Pertussis Pathway (218102); Pertussis Pathway (218099); Pertussis Pathogenicity Signature 1, Pertussis Toxin Pathway (704416); Pertussis Pathogenicity Signature 1, Pertussis Toxin Pathway (705375)
size1 :
0.05 mg (E-Coli)
price1 :
185 USD
size2 :
0.2 mg (E-Coli)
price2 :
420
size3 :
0.5 mg (E-Coli)
price3 :
680
size4 :
1 mg (E-Coli)
price4 :
1070
more info or order :
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!